Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

U.S. IPO: Biotech IPOs Keep Flowing As Data Center Developer DayOne Joins The Pipeline

10 October 2026

MS&AD Insurance Group Holdings, Inc. (MSADY) Discusses Strategic Management Changes and Group Reorganization Amid Market Uncertainties Transcript

10 October 2026

enCore Energy: Production Needs To Catch Up With Its Contracts (NASDAQ:EU)

9 October 2026

Robert Half: Stabilizing Macro But Potential AI Headwinds (NYSE:RHI)

9 October 2026

MFICL: MidCap Financial’s 8.38% Baby Bond Offers The Superior Risk-Adjusted Play

9 October 2026
Facebook X (Twitter) Instagram
Business Saturday, Oct 10
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » U.S. IPO: Biotech IPOs Keep Flowing As Data Center Developer DayOne Joins The Pipeline
News

U.S. IPO: Biotech IPOs Keep Flowing As Data Center Developer DayOne Joins The Pipeline

thebusinesstimes.co.ukBy thebusinesstimes.co.uk10 October 20260 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Share
Facebook Twitter LinkedIn Pinterest Email

Renaissance Capital provides pre-IPO research to institutional investors and investment banks. The Firm manages two IPO-focused funds: The Renaissance IPO ETF (NYSE: IPO) and the Renaissance International IPO ETF (NYSE: IPOS). Individual investors can get a free overview of the IPO market on www.renaissancecapital.com, and try a free trial of our premium platform, IPO Pro (ipopro.renaissancecapital.com). Through Renaissance Capital’s pre-IPO research service, institutional investors get an independent opinion, in-depth fundamental analysis, and customizable financial models on all IPOs.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

MS&AD Insurance Group Holdings, Inc. (MSADY) Discusses Strategic Management Changes and Group Reorganization Amid Market Uncertainties Transcript

enCore Energy: Production Needs To Catch Up With Its Contracts (NASDAQ:EU)

Robert Half: Stabilizing Macro But Potential AI Headwinds (NYSE:RHI)

MFICL: MidCap Financial’s 8.38% Baby Bond Offers The Superior Risk-Adjusted Play

What Investors Should Do After Lenovo Shares Dipped (OTCMKTS:LNVGY)

New Horizon Aircraft Ltd. (HOVR) Q1 2027 Earnings Call Transcript

Teva Pharmaceutical Industries Limited (TEVA) Discusses FDA Approval of Weltruza and Strategic Growth Initiatives Transcript

I Test Drove Meta’s Muse: I Expected Little, And It Delivered Much Less (NASDAQ:META)

How To Position In A High Interest Rate Environment (NYSEARCA:EDV)

Editors Picks

MS&AD Insurance Group Holdings, Inc. (MSADY) Discusses Strategic Management Changes and Group Reorganization Amid Market Uncertainties Transcript

10 October 2026

enCore Energy: Production Needs To Catch Up With Its Contracts (NASDAQ:EU)

9 October 2026

Robert Half: Stabilizing Macro But Potential AI Headwinds (NYSE:RHI)

9 October 2026

MFICL: MidCap Financial’s 8.38% Baby Bond Offers The Superior Risk-Adjusted Play

9 October 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

What Investors Should Do After Lenovo Shares Dipped (OTCMKTS:LNVGY)

9 October 2026

New Horizon Aircraft Ltd. (HOVR) Q1 2027 Earnings Call Transcript

9 October 2026

Teva Pharmaceutical Industries Limited (TEVA) Discusses FDA Approval of Weltruza and Strategic Growth Initiatives Transcript

9 October 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.